Publications by authors named "Jamie Mullen"

Claim this Profile
L
Lanabecestat: Neuroimaging results in early symptomatic Alzheimer's disease.
Jennifer A Zimmer, Sergey Shcherbinin, Michael D Devous, Sonja M Bragg, Katherine J Selzler, Jamie Mullen

Alzheimers Dement (N Y)· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retinal Functional and Structural Changes in the 5xFAD Mouse Model of Alzheimer's Disease.
Jeremiah K H Lim, Qiao-Xin Li, Zheng He, Algis J Vingrys, Holly R Chinnery, Jamie Mullen

Front Neurosci· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinically Negligible Pharmacokinetic and Pharmacodynamic Interactions Between Lanabecestat and Dabigatran Etexilate, a Prototypical P-gp Substrate.
Scott A Monk, Alan R Kugler, Scott W Andersen, Mosun A Ayan-Oshodi, Douglas E James, Jamie Mullen

J Clin Pharmacol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Lanabecestat for Treatment of Early and Mild Alzheimer Disease: The AMARANTH and DAYBREAK-ALZ Randomized Clinical Trials.
Alette M Wessels, Pierre N Tariot, Jennifer A Zimmer, Katherine J Selzler, Sonja M Bragg, Jamie Mullen

JAMA Neurol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population Pharmacokinetic Modeling With Enterohepatic Circulation for AZD3241 in Healthy Subjects and Patients With Multiple System Atrophy.
Xiao Tong, Diansong Zhou, Alicia Savage, Jamie A Mullen, Yan Li

J Clin Pharmacol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Bioavailability of the Novel BACE1 Inhibitor Lanabecestat (AZD3293): Assessment of Tablet Formulations Versus an Oral Solution and the Impact of Gastric pH on Pharmacokinetics.
Naidong Ye, Scott A Monk, Pankaj Daga, David M Bender, Laura B Rosen, Jamie Mullen

Clin Pharmacol Drug Dev· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Eye As a Biomarker for Alzheimer's Disease.
Jeremiah K H Lim, Qiao-Xin Li, Zheng He, Algis J Vingrys, Vickie H Y Wong, Jamie Mullen

Front Neurosci· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quetiapine for the treatment of bipolar mania in older adults.
Martha Sajatovic, Joseph R Calabrese, Jamie Mullen

Bipolar Disord· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reporting outcomes in clinical trials for bipolar disorder: a commentary and suggestions for change.
Anabel Martinez-Arán, Eduard Vieta, K N Roy Chengappa, Samuel Gershon, Jamie Mullen

Bipolar Disord· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quetiapine in the treatment of acute mania: target dose for efficacious treatment.
Eduard Vieta, Joseph F Goldberg, Jamie Mullen, Mårten Vågerö, Björn Paulsson

J Affect Disord· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rates of remission/euthymia with quetiapine in combination with lithium/divalproex for the treatment of acute mania.
Norman Sussman, Jamie Mullen, Björn Paulsson, Mårten Vågerö

J Affect Disord· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quetiapine or haloperidol as monotherapy for bipolar mania--a 12-week, double-blind, randomised, parallel-group, placebo-controlled trial.
Roger S McIntyre, Martin Brecher, Björn Paulsson, Karin Huizar, Jamie Mullen

Eur Neuropsychopharmacol· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression.
Joseph R Calabrese, Paul E Keck, Wayne Macfadden, Margaret Minkwitz, Terence A Ketter, Jamie Mullen

Am J Psychiatry· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quetiapine monotherapy for mania associated with bipolar disorder: combined analysis of two international, double-blind, randomised, placebo-controlled studies.
Eduard Vieta, Jamie Mullen, Martin Brecher, Björn Paulsson, Martin Jones

Curr Med Res Opin· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder.
Charles L Bowden, Heinz Grunze, Jamie Mullen, Martin Brecher, Björn Paulsson

J Clin Psychiatry· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quetiapine versus placebo in combination with lithium or divalproex for the treatment of bipolar mania.
Lakshmi N Yatham, Björn Paulsson, Jamie Mullen, And Mårten Vågerö

J Clin Psychopharmacol· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comparison of extrapyramidal symptoms in older outpatients treated with quetiapine or risperidone.
Jacobo E Mintzer, Jamie A Mullen, Dennis E Sweitzer

Curr Med Res Opin· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A random-assignment, double-blind, clinical trial of once- vs twice-daily administration of quetiapine fumarate in patients with schizophrenia or schizoaffective disorder: a pilot study.
K N Roy Chengappa, Haranath Parepally, Jaspreet S Brar, Jamie Mullen, Ann Shilling

Can J Psychiatry· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of quetiapine and risperidone against depressive symptoms in outpatients with psychosis.
Martha Sajatovic, Jamie A Mullen, Dennis E Sweitzer

J Clin Psychiatry· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis